Desnos-Ollivier, M., Lortholary, O., Bretagne, S., and Dromer, F.: Azole Susceptibility Profiles of More than 9,000 Clinical Yeast Isolates Belonging to 40 Common and Rare Species, Antimicrob. Agents Chemother., 65, e02615-20, https://doi.org/10.1128/AAC.02615-20, 2021.  

Gamaletsou, M. N., Kontoyiannis, D. P., Sipsas, N. V., Moriyama, B., Alexander, E., Roilides, E., Brause, B., and Walsh, T. J.: Candida Osteomyelitis: Analysis of 207 Pediatric and Adult Cases (1970–2011), Clin. Infect. Dis., 55, 1338–1351, https://doi.org/10.1093/cid/cis660, 2012. 

Gamaletsou, M. N., Rammaert, B., Brause, B., Bueno, M. A., Dadwal, S. S., Henry, M. W., Katragkou, A., Kontoyiannis, D. P., McCarthy, M. W., Miller, A. O., Moriyama, B., Pana, Z. D., Petraitiene, R., Petraitis, V., Roilides, E., Sarkis, J.-P., Simitsopoulou, M., Sipsas, N. V., Taj-Aldeen, S. J., Zeller, V., Lortholary, O., and Walsh, T. J.: Osteoarticular Mycoses, Clin. Microbiol. Rev., 35, e00086-19, https://doi.org/10.1128/cmr.00086-19, 2022. 

Pfaller, M. A., Messer, S. A., Rhomberg, P. R., Jones, R. N., and Castanheira, M.: Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates, J. Antimicrob. Chemother., 71, 2868–2873, https://doi.org/10.1093/jac/dkw214, 2016. 

Sandison, T., Ong, V., Lee, J., and Thye, D.: Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults, Antimicrob. Agents Chemother., 61, e01627-16, https://doi.org/10.1128/AAC.01627-16, 2017.